IP Library Granted Patent US 7,985,832
Granted Patent B2
US 7,985,832 · App. 12/087,228 · Granted Jul 26, 2011

Antimicrobial cathelicidin peptides

Assignee: Kansas State University Research Foundation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,985,832
App. No.
12/087,228
Granted
Jul 26, 2011
Kind
B2
Abstract

The invention relates to antimicrobial cathelicidin polypeptides related to a 38 amino acid peptide having SEQ ID NO:4. The invention provides for polypeptides having broad spectrum antimicrobial activity, nucleic acids and expression vectors encoding such polypeptides, as well as host cells and methods of reducing survival of a microbe. In addition, the invention also provides compositions, as well as articles of manufacture, that comprise a broad spectrum antimicrobial polypeptide.

Claims (14)

1. A purified polypeptide consisting of SEQ ID NO: 4, a variant of SEQ ID NO: 4 having at least 80% amino acid sequence identity to SEQ ID NO: 4, or a fragment thereof having at least 15 contiguous amino acids of SEQ ID NO: 4 or the variant thereof.

2. The purified polypeptide of claim 1 wherein the variant has at least 90% amino acid sequence identity to SEQ ID NO: 4.

3. The purified polypeptide of claim 1 wherein the variant has 1 to 4 conservative amino acid substitutions.

4. The purified polypeptide of claim 1 wherein the fragment comprises at least 25 contiguous amino acids of SEQ ID NO: 4.

5. A composition comprising the polypeptide, the variant or the fragment of claim 1 .

6. The composition of claim 5 further comprising a pharmaceutically acceptable carrier or a food additive.

7. A method of inhibiting microbial growth comprising contacting the microorganism with an effective amount of the polypeptide, the variant or the fragment of claim 1 .

8. The method of claim 7 wherein the growth of a Gram-positive bacterium, a Gram-negative bacterium, a yeast or a protozoan is inhibited.

9. The method of claim 7 wherein the microbe is the causative agent of a food-borne illness or a sexually transmitted disease.

10. The method of claim 9 wherein the disease is syphilis, chlamydia, gonorrhoeae, trichomoniasis, or thrush.

11. The method of claim 7 wherein the microbe is Listeria monocytogenes, Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, Salmonella typhimurium, Pseudomonas aeruginosa, Proteus mirabilis, Salmonella enteritidis, Neisseria gonorrhoeae, Ureaplasma canigenitalium, Ureaplasma urealyticum, Candida albicans , or Trichomonas vaginalis.

12. An article of manufacture comprising the polypeptide, the variant or the fragment of claim 1 .

13. The purified polypeptide of claim 1 , wherein the variant or fragment has a deletion at the amino or the carboxy terminus.

14. The purified polypeptide of claim 1 , having a sequence consisting of any of SEQ ID NOs: 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, or a combination thereof.

Assignments (3)
CONFIRMATORY LICENSE Recorded Feb 23, 2015
From: KANSAS STATE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 035070/0895 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 3, 2009
From: MELGAREJO, TONATIUH; BLECHA, FRANK; SANG, YONGMING; ORTEGA, MARIA TERESA
To: KANSAS STATE UNIVERSITY RESEARCH FOUNDATION
Reel/Frame 022777/0372 →
CONFIRMATORY LICENSE Recorded Feb 9, 2009
From: KANSAS STATE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 022227/0809 →
Continuity (2)
Provisional Application 60754878 · Dec 29, 2005
Related Publication 20090221483A1 · Sep 3, 2009